MM3 Stock Overview
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Merit Medical Systems, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$68.00 |
| 52 Week High | US$79.50 |
| 52 Week Low | US$58.50 |
| Beta | 0.91 |
| 1 Month Change | 4.62% |
| 3 Month Change | -5.56% |
| 1 Year Change | -3.55% |
| 3 Year Change | 36.55% |
| 5 Year Change | 33.52% |
| Change since IPO | 563.03% |
Recent News & Updates
Recent updates
Shareholder Returns
| MM3 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 2.3% | -2.1% | -0.8% |
| 1Y | -3.5% | -3.3% | 1.0% |
Return vs Industry: MM3 matched the German Medical Equipment industry which returned -3.3% over the past year.
Return vs Market: MM3 underperformed the German Market which returned 1% over the past year.
Price Volatility
| MM3 volatility | |
|---|---|
| MM3 Average Weekly Movement | 3.5% |
| Medical Equipment Industry Average Movement | 4.5% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 9.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: MM3 has not had significant price volatility in the past 3 months.
Volatility Over Time: MM3's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 6,950 | Fred Lampropoulos | www.merit.com |
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.
Merit Medical Systems, Inc. Fundamentals Summary
| MM3 fundamental statistics | |
|---|---|
| Market cap | €3.97b |
| Earnings (TTM) | €88.86m |
| Revenue (TTM) | €1.18b |
44.6x
P/E Ratio3.4x
P/S RatioIs MM3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MM3 income statement (TTM) | |
|---|---|
| Revenue | US$1.26b |
| Cost of Revenue | US$673.49m |
| Gross Profit | US$583.87m |
| Other Expenses | US$489.46m |
| Earnings | US$94.41m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 30, 2024
| Earnings per share (EPS) | 1.63 |
| Gross Margin | 46.44% |
| Net Profit Margin | 7.51% |
| Debt/Equity Ratio | 68.5% |
How did MM3 perform over the long term?
See historical performance and comparison